SCHEMBL7303514

SCHEMBL7303514

COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)NC(=O)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACE P12821 10/20 0.64
ALDH1A1 P00352 2/20 0.62
CYP3A4 P08684 1/20 0.62
TSHR P16473 1/20 0.62
REN P00797 1/20 0.59
ACE2 Q9BYF1 6/20 0.55
FKBP1A P62942 1/20 0.54
PREP P48147 2/20 0.54
KLK5 Q9Y337 1/20 0.53
CTRB1 P17538 1/20 0.52
ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18620591 1.00 ACE (0.64) ACEALDH1A1CYP3A4TSHRREN
SCHEMBL18088488 0.92 ACE (0.60) ACEALDH1A1CYP3A4TSHRREN
SCHEMBL8268894 0.91 ACE (0.76) ACERENACE2
SCHEMBL8261181 0.91 ACE (0.76) ACERENACE2
SCHEMBL9477156 0.91 ACE (0.76) ACERENACE2
SCHEMBL6979828 0.91 ACE (0.76) ACERENACE2
SCHEMBL5970431 0.91 ACE (0.76) ACERENACE2
SCHEMBL9574253 0.91 ACE (0.76) ACERENACE2
SCHEMBL7321218 0.90 ACE (0.60) ACEALDH1A1CYP3A4TSHRREN
SCHEMBL20173778 0.90 REN (0.60) ACEALDH1A1CYP3A4TSHRREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583146-A Heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-10 US disclosed
US-5561146-A Modified guanidino and amidino thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-01 US disclosed
EP-0686642-A2 Modified guanidino and amidino thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-12-13 EP disclosed
EP-0601459-A2 Sulfonamido heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-15 EP disclosed